Regarding vaccines, Rao said:
"I have used domestic inactivated vaccine, no side effects and high antibody. I know overseas relatives with mRNA vaccines usually get fevers. So, I recommend that people in China use domestic vaccines."
However, Rao also said that if there are vaccines or medicines abroad that are better than those made in China, we should allow them to be used
"If there is a vaccine or medicine abroad that is better than our own, we should allow everyone to use it. We, China, have the courage to admit that we still lag behind the forefront of the world in many aspects. Our pride does not require us to surpass other countries immediately, but we have been able to work together and make unremitting efforts over the long term to get out of the historic low point and make progress step by step. Our confidence lies not in the short term, but in the long term and the future."
There are two updates on vaccines and drugs.
1. December 8, Reuters reported that German Health Minister Karl Lauterbach said he had granted China Sinovac a license to import its vaccines into Germany from Wednesday, and that people who received Sinovac vaccines would be treated as having received the vaccine, a status previously granted only to those who received the vaccine approved by Germany. The vaccine will be available to Chinese citizens in Germany, and Lauterbach hopes to give them more protection against the coronavirus. Reuters commented that Germany's approval of Sinovac paves the way for China's equivalent approval of bubicide vaccine.
2. Pfizer Paxlovid (Nematavir tablet/Ritonavir tablet combination) has been conditionally approved in China as early as February this year, and has been included in the medical insurance. Domestic drugs are not bad, for example, Jun Shi Bio has announced that its novel coronavirus oral small molecule drug VV116 has excellent effect in Pfizer Paxlovid, and better safety. We look forward to the publication of this head-to-head clinical study in an academic journal.
